Overview
InDevR provides multiplexed analytical solutions via its VaxArray platform for vaccine development, optimization, and quality control, supporting mRNA, polysaccharide, conjugate, and viral vector vaccines. The platform offers validated off-the-shelf and custom kits, such as 5'CapQ for rapid mRNA capping efficiency assessment in under two hours and pneumococcal assays for 23 serotypes in a single test. Acquired by SSI Diagnostica Group, InDevR also delivers expert services to streamline workflows and enhance assay sensitivity for pharmaceutical manufacturers.
Frequently asked questions
- What is InDevR's VaxArray platform?
- VaxArray is an automated, microarray-based multiplexed platform offering validated and custom kits to simplify vaccine workflows, enabling simultaneous quantification of multiple analytes like serotypes or mRNA quality attributes in a single test.
- What vaccine types does InDevR support?
- InDevR supports mRNA, polysaccharide, conjugate, pneumococcal, and viral vector vaccines with specialized assays for in-process control, potency, stability, and quality assessment.
- Where is InDevR located and how to contact?
- InDevR is based in Boulder, Colorado, USA at 6035 Longbow Dr., Suite 102. Contact [email protected] or +1 303-402-9100 for inquiries.